FORMULATION
植物配方
Botanical formulation
从植物来源、配方研究到营养支持，了解产品的研发脉络。
Explore the development of the botanical formula and its nutritional role.
认识配方About the formulationREVAION · Dibifree180®
从此刻，看见更好的选择。
由 Revaion 影音开启，认识 Dibifree180® 的植物营养支持。
See a better choice from this moment.
Begin with Revaion, then discover Dibifree180® botanical nutrition support.
植物营养 · 442 饮食指导 · AI 智能卫教Botanical nutrition · 442 food guidance · AI education
LIGHTAIRWATERPLANT
0102
抗糖新观念
Glucose support
从植物原料的研究，到三餐与 180 天的个别陪伴。
From botanical research to meals and 180 days of individual support.
减重智取胜
Weight support
从减重到长期维持，提前规划营养与生活支持。
Plan nutrition and daily-life support for long-term weight care.
从配方，到生活。
From formulation to everyday life.
BOTANICAL NUTRITION · EVERYDAY CARE
Dibifree180®，让营养有方向。
Dibifree180®. A starting point for nutrition.
每天怎么吃、如何记录、遇到问题和谁讨论，都是照护的一部分。
Meals, daily records and someone to turn to: each has a place in everyday care.
从植物配方到 442 饮食指导，再到持续回馈，Dibifree180® 把营养支持连回生活。
Dibifree180® connects its botanical formula with 442 food guidance and ongoing feedback.
认识基诺华Meet GeninovaPUBLICATION
国际期刊
International publication
研究发表于 Food Research International，可直接查阅原文与研究设计。
Read the study published in Food Research International and examine its design.
阅读论文Read the publicationHUMAN STUDY
人体研究
Human study
40 位第二型糖尿病成人参与，观察血糖及体重相关指标。
Forty adults with type 2 diabetes participated, with glucose and weight-related outcomes assessed.
了解研究设计Explore the study design研究期程为 7 个月，与 180 天服务安排分开呈现；个别结果请依研究条件理解。
The study lasted seven months and is presented separately from the 180-day service. Interpret individual outcomes within the study context.
Food Research International · 223 (2026) 117820 ↗
AI 智能卫教
AI-powered education
DR. DB · EVERYDAY NUTRITION & CARE
吃得明白，记得轻松。
让照护走进日常。Understand your meals.
Build a daily care routine.
每天怎么吃、怎么记录、遇到问题问谁？Dr. DB 的照护规划，串连饮食卫教、日常纪录与专业团队，让 180 天的营养支持更容易理解与执行。What should I eat, what should I record, and who can help? The Dr. DB care concept connects food education, daily records and professional follow-up across a 180-day nutrition journey.
把营养，带回每一餐。Bring nutrition to the table.
从食材选择开始，让饮食指导更容易融入生活。Start with ingredients that make everyday food guidance easier to follow.
把纪录，变成日常。Make a habit of checking in.
餐食、活动与日常纪录，让每次回顾都有讨论的起点。Meals, activity and daily records give each follow-up a place to begin.
随时提问，持续卫教Ask questions throughout your day
把日常疑问整理清楚，从餐前选择到外食安排，让卫教更贴近生活；需要专业判断时，再衔接照护团队。Organize everyday questions, from meal planning to eating out. Connect with the care team when professional judgment is needed.
442 饮食，落实到餐桌442 guidance for real meals
从纤维、蛋白质与油脂出发，依个人安排讨论食材与份量，把 442 原则带进每一餐。Discuss ingredients and portions within the personal plan, bringing the 442 approach to everyday meals.
用熟悉的语言，理解照护Care in a familiar language
配合熟悉的语言、在地食材与饮食习惯，让说明容易理解。可用语言与地区于咨询时确认。Use familiar language, local ingredients and food habits. Confirm available languages and regions during consultation.
依所在地核对药品资料Medication context for your location
整理现有用药与所在地资料，让专业团队核对药品名称及仿单；各地核准资讯分别查核。Organize current medicines and location details for professional review of names and labels. Local approvals are checked separately.
Dibifree180® 个人化营养指导Personalized Dibifree180® nutrition guidance
一起讨论产品资讯、442 饮食与生活纪录；搭配目前药物是否合适，由医师或药师评估。Review product information, 442 food guidance and daily records together. A physician or pharmacist assesses suitability with current medicines.
AI 整理，专业团队接手AI organization, professional follow-up
汇整餐食、体重、血糖与回馈，让每次讨论更有方向。检验判读、用药与照护调整由适格专业人员处理。Bring meals, weight, glucose and feedback into each review. Qualified professionals handle test interpretation, medicines and changes to care.
先记住 442：纤维、蛋白、好油。
Start with 442: fibre, protein and good oils.
依公司 442 方针，不纳入淀粉类食物；实际份量由卫教团队协助确认。
The company’s 442 approach excludes starchy foods. Confirm individual portions with the education team.
膳食纤维
Dietary fibre
纤维蔬菜
Fibrous vegetables
优质蛋白质
Quality protein
鱼・肉・豆・蛋
Fish · meat · beans · eggs
好油
Good oils
橄榄油・酪梨油・苦茶油
Olive · avocado · tea seed oil
180 天，持续记录与复评。180 days of records and review.
- 起点START
一起了解你
Understand your starting point
开通 Dr. DB，整理现有检验、用药、平日餐食与目标，建立个人照护起点。
Activate Dr. DB and review current results, medicines, meals and personal goals.
- 每天DAILY
记录，也有回馈
Record and receive feedback
透过 Dr. DB 提问与记录，依个人安排回报餐食、血糖与体重，让 AI 卫教与团队追踪持续衔接。
Use Dr. DB for questions and records, sharing meals, glucose and weight as individually arranged to connect AI education with team follow-up.
- 第 30 天DAY 30
回看第一个月
Review the first month
回顾餐食、纪录与生活变化，一起调整接下来的做法。
Review food choices, records and daily-life changes, then adjust the next steps.
- 第 90 天DAY 90
一起做中期复评Review at the midpoint
由 AI 整理阶段纪录，与专业团队回顾饮食执行、身体指标及使用回馈，确认后续照护重点。AI organizes records for the care team to review food routines, health markers and feedback, and agree on priorities for the next stage.
- 第 180 天DAY 180
看进度，也看下一步
Review progress and plan ahead
整理这段时间的纪录与检验，讨论下一阶段如何维持。
Review the accumulated records and results, and discuss the next stage.
这是服务流程介绍；个别项目与回馈频率于咨询时确认。
This outlines the service journey. Confirm individual services and feedback frequency during consultation.
先谈需求，再确认适合的安排。Start with your needs.
告诉我们你的饮食目标与所在地，由团队说明方案内容、服务地区及 Dr. DB 的可用安排，再一起讨论下一步。Tell us about your food goals and location. The team can explain the plan, service regions and Dr. DB availability, then discuss your next step.
咨询照护方案Discuss the care plan在地化规划与资料来源Local care planning and references
LOCAL CONTEXT · TRACEABLE KNOWLEDGE
同一套照护核心，依所在地调整。One care approach, adapted to your location.
Dr. DB 的知识架构分为公司卫教 know-how、当地核准仿单、适用临床指南与个人照护纪录。法规核准与临床指南分别核对，保留来源与更新日期；资料不足或涉及个人用药决策时，交由专业人员确认。Dr. DB’s knowledge framework separates company education know-how, local approved labels, relevant clinical guidelines and personal care records. Regulatory approvals and clinical guidelines are checked separately, with sources and dates retained. Missing evidence and personal medication decisions require professional review.
北美North America
依实际国家核对药品资料；美国以 FDA 核准仿单为查核来源之一。Check the specific country. In the US, FDA-approved labels are one reference.
欧洲Europe
区分欧盟与其他欧洲市场，核对 EMA 资料及服务所在地的规范。Distinguish EU and other European markets; check EMA information and local requirements.
中东Middle East
逐国确认当地药品核准与卫教情境，例如沙乌地阿拉伯 SFDA 资料。Verify approvals and education context country by country, including Saudi SFDA information.
亚洲与南岛语族服务情境Asia and Austronesian-language communities
依居住国家、语言、饮食习惯及个人病况调整；族群名称不直接决定用药方案。Adapt to country of residence, language, food culture and individual health. Ethnic identity alone does not determine medication choices.
以上为知识架构与在地化方向；可用地区、语言及资料涵盖范围于开通时确认。产品与药物的搭配评估，需另外核对个别配方、病况与交互作用证据。This describes the knowledge and localization approach. Available regions, languages and evidence coverage are confirmed at onboarding. Combining a product with medicines requires separate review of its formulation, the person’s condition and interaction evidence.
药品资讯查核入口Medication information references
美国 FDA 药品资料库 ↗US FDA drug databases ↗台湾 TFDA 药品资讯 ↗Taiwan TFDA drug information ↗EMA · Wegovy ↗Saudi SFDA ↗AI 提供卫教与纪录整理，不自行诊断、开药或调整剂量。Dibifree180® 为保健食品；个人用药及营养安排需依专业评估。AI provides education and record organization; it does not diagnose, prescribe or change doses. Dibifree180® is a dietary supplement. Medication and nutritional arrangements require individual professional assessment.
每段经历，都有生活的样子。
The everyday stories behind the journey.
从不爱运动，到有人陪著持续。
From avoiding exercise to finding a routine.
卫教课程、跑步机与云端回报，慢慢成为日常的一部分。
Education sessions, treadmill activity and online feedback gradually became part of daily life.
糖友见证集第七版・第 25 页
Seventh-edition accounts · p.25
阅读这段经历Read the account聚餐的压力，可以一起面对。
Support through social-meal pressure.
有家人备餐与同伴鼓励，也有朋友劝吃的困难。餐食调整，需要生活里的支持。
Family meal preparation and peer encouragement offered support, alongside the challenges of eating socially.
第二型糖尿病个案的体重管理经验・第 23–24 页
Weight-management experience in type 2 diabetes · pp.23–24
阅读这段经历Read the account见证呈现饮食、活动与其他照护共同参与的个人经验，不能单独证明产品效果。
These personal accounts include changes in diet, activity and other care; they do not independently establish product effects.
从你的需要，找到下一步。
Find your next step.
糖友与购买者
Individuals & purchasers
了解 Dibifree180®、方案内容与开始方式。
Learn about Dibifree180®, the program and how to begin.
网红与内容创作者
Creators & influencers
分享你的平台、受众与内容合作想法。
Share your platform, audience and content ideas.
经销商与代理商
Distributors & agents
说明所在市场与服务对象，讨论合作。
Tell us your market and audience to explore a partnership.
志愿者与社群支持
Volunteers & communities
留下希望参与的方式与可投入的时间。
Tell us how you would like to contribute and your availability.
需要更进一步了解个人差异？
Want to explore individual differences further?
基因检测为公司的延伸服务，依需求咨询后，再讨论适用的评估方式。
Genetic testing is an additional company service. Discuss your needs before considering an assessment.
如有癌症辅疗基因检测咨询需求，请与我们个别联络。
For cancer-support genetic testing inquiries, please contact us individually.
个别联络Contact usGENINOVA · OUR STORY
研究植物，
让科学走进
日常生活。
基诺华以植物药研究为根基，连结配方开发、人体研究与个人化健康服务。
Rooted in plants.
Focused on people.
Geninova connects botanical medicine research with formulation development, human studies and personalized health services.
RESEARCH INTO EVERYDAY CARE
从研究出发，
把照护带进生活。
串起植物研究、配方开发与专业判读，让营养支持与健康纪录回到每个人的日常。
From research to everyday care.
We bring botanical research, formulation development and professional interpretation into everyday nutrition and health records.
BOTANICAL NUTRITION
植物营养，走进生活。
Botanical nutrition for everyday life.
Dibifree180® 连结植物配方、饮食指导与持续陪伴。从每天的一餐、一份纪录，建立适合自己的照护节奏。
Dibifree180® brings together botanical nutrition, food guidance and ongoing support. Build your care routine, one meal and one record at a time.
- Dibifree180®植物配方Botanical formulation
- 442饮食指导Food guidance
- 180天持续陪伴Days of support
NATURE, STUDIED WITH RIGOR.
尊重自然，也尊重证据。
从植物来源、活性成分到人体研究，让研发的每一步都有迹可循。
Respecting nature and evidence.
From plant origins and active compounds to human studies, research should remain traceable at every step.
OUR BRAND
You have better choices.
You have better choices.
把植物研究带进产品开发，让人们更了解日常营养的选择。
Bringing botanical research into product development, and making everyday nutritional choices easier to understand.
公司原有跨产品宣传图。Dibifree180® 的人体研究与适用范围，请见科研证据；营养补充不作为处方药或疫苗的替代。
Original cross-product brand artwork. See Science for the Dibifree180® human study and its scope. Nutritional supplementation does not replace prescribed medication or vaccination.
PUBLIC MILESTONES
研发有历程，证据可追溯。
从研究完成、公开登记到论文发表，查阅各阶段的来源与纪录。
A research journey you can trace.
Follow the sources and records, from study completion and registration to publication.
人体研究完成结案与解盲
公司研究资料记载完成随机双盲研究与解盲；后续正式论文公开研究设计与分析结果。
Human study completed and unblinded
Company records document study completion; the later peer-reviewed paper reports its design and analysis.
Virofree 研究发表
计算研究连接细胞与生化验证，刊于 Frontiers in Pharmacology。
Virofree research published
Computational work connected with cellular and biochemical validation in Frontiers in Pharmacology.
Dibifree 研究公开登记
研究设计、观察指标与登记历程公开于 ClinicalTrials.gov。
Dibifree trial registered
The study design, outcomes and record history are public on ClinicalTrials.gov.
随机对照研究正式刊载
40人分析结果刊于 Food Research International 223，并收录于 PubMed。
Randomized controlled study published
The 40-participant analysis appeared in Food Research International 223 and is indexed in PubMed.
02 · CORE PLATFORM
精准测量之后，
真正重要的是
如何行动。
个人精准健康风险地图＋180天个人化管理＋年度健康长寿服务。
After precision measurement,
what matters is
how we act.
A personal precision health map, a 180-day management plan and ongoing longevity support.
THE HEALTH LOOP
从生命数据到持续改善的完整闭环
A complete loop from life data to continuous improvement
THREE CONNECTED LAYERS
数据与判读层
整合适用的基因、临床生物标志、体组成、生活方式与用药资讯，建立个人风险与管理优先序。
Data & Interpretation
Integrate relevant genetics, clinical biomarkers, body composition, lifestyle and medication data to define personal risk and priorities.
个人化干预层
把判读转化为可执行的药物建议、保健食品建议、植物营养、饮食、运动与睡眠方案；药物须由医师评估，保健食品则由专业团队依用药与个人风险共同确认。
Personalized Intervention
Translate insights into actionable medication guidance, health-food and supplement guidance, botanical nutrition, diet, movement and sleep plans. Medication decisions require physician review, while supplement use is checked by the professional team against medications and individual risks.
持续服务与交付层
透过AI辅助追踪、90／180天复评与年度会员服务，累积真实变化并优化下一阶段。
Longitudinal Delivery
Use AI-assisted follow-up, 90/180-day reassessment and annual services to learn from real change and refine the next stage.
CARE IN EVERYDAY LIFE
让照护回到生活。
Make care part of everyday life.
从植物营养、个人健康纪录到专业讨论，把每天的饮食、活动与追踪连在一起。数据帮助理解变化，服务回到每个人的生活与目标。
Connect botanical nutrition, personal records and professional conversations with meals, activity and follow-up. Use data to understand change and shape care around each person’s life and goals.
- 植物营养Botanical nutrition
- 健康纪录Health records
- 个人化照护Personalized care
- 持续回馈Ongoing feedback
依需求选择基因服务
Find a genomic service
GENINOVA GENOMIC SERVICES
基因检测不只找出差异，
更要让结果成为
可以采取的下一步。
基因检测是 Dibifree180® 营养干预之外的个别评估服务，依糖尿／减糖、减重与免疫相关需求，讨论适合的检测与后续判读。
Genomic testing should do more than identify differences.
It should inform
the next decision.
Genomic testing is a separate assessment service alongside Dibifree180® nutritional intervention, addressing glucose, weight and immune-related questions through individual consultation.
05 · END-TO-END GENOMICS
全链式基因检测服务
从需求定义到结果交付，一条服务链完成，不把客户留在只有原始数据的阶段。
依个人健康、医疗、研究或产品开发情境，由基诺华团队规划适合的检体与技术路径，完成品质确认、定序、生物资讯分析、结果注释与专业报告，并可衔接后续生命数据管理。
End-to-End Genomic Testing
One connected workflow from defining the question to delivering an interpretable result.
For personal health, clinical, research or product-development needs, the Geninova team plans the specimen and technical pathway, performs quality review, sequencing, bioinformatics, annotation and professional reporting, with optional integration into longitudinal health-data management.
- 01需求与检体规划厘清使用情境、样本条件与分析目标Scope & specimenDefine context, specimen conditions and analytical goals
- 02实验与品质流程核酸处理、品质确认与适用定序流程Laboratory & qualityNucleic-acid preparation, quality review and suitable sequencing
- 03生物资讯分析资料处理、变异辨识、注释与品质检查BioinformaticsData processing, variant calling, annotation and quality checks
- 04报告与后续整合专业报告、沟通支援与长期资料衔接Report & integrationProfessional reporting, communication support and longitudinal integration
ONE IN-HOUSE WORKFLOW
不是只交付一份检测结果，而是把问题、数据与决策连起来。
客户直接与基诺华团队讨论需求；同一服务流程负责专案设计、检体条件、分析逻辑、报告内容及后续应用沟通。
We connect the question, the data and the decision.
Clients work directly with the Geninova team across project design, specimen requirements, analytical logic, report content and follow-through.
GENINOVA FULL-SERVICE SOP
从第一次咨询，到90／180天复评。
From the first inquiry to 90/180-day reassessment.
客户不必自行协调不同单位。业务、服务人员、护理师、医师、实验室与产品团队依同一案件进度接力，每一步都有负责角色、交付成果与下一个明确动作。
Clients do not need to coordinate separate providers. Business, service, nursing, physician, laboratory and product teams work from one case pathway, with a clear owner, deliverable and next action at every step.
01接案与评估Intake & assessment
02采检与分析Collection & analysis
03判读与交付Review & delivery
04持续追踪Ongoing follow-up
01服务入口ENTRY
客户咨询
负责角色｜客户服务
- 客户取得
- 需求确认与咨询编号
- 下一步
- 补充基本需求与联络方式
- 参考时程
- 起始日
Client inquiry
Owner | Client service
- Deliverable
- Inquiry record and case number
- Next
- Confirm needs and contact details
- Timing
- Starting day
02单一窗口ONE CONTACT
专人接案
负责角色｜业务、服务经理
- 客户取得
- 服务方向与所需资料清单
- 下一步
- 安排医师初评
- 参考时程
- 咨询后1–2个工作日
Case assignment
Owner | Business & service manager
- Deliverable
- Service direction and information checklist
- Next
- Schedule physician assessment
- Timing
- 1–2 business days after inquiry
03临床入口CLINICAL GATE
医师初评
负责角色｜医师
- 客户取得
- 适用性评估与检测方向
- 下一步
- 确认检体、方案与必要转介
- 参考时程
- 依门诊或线上评估安排
Physician assessment
Owner | Physician
- Deliverable
- Suitability review and testing direction
- Next
- Confirm specimen, plan and referral needs
- Timing
- By clinic or online assessment schedule
04服务协调COORDINATION
护理／服务安排
负责角色｜护理师、服务专员
- 客户取得
- 预约、采检说明与行前准备
- 下一步
- 依预约完成采检
- 参考时程
- 初评完成后安排
Care coordination
Owner | Nurse & service coordinator
- Deliverable
- Appointment and collection instructions
- Next
- Complete scheduled collection
- Timing
- Arranged after assessment
05品质关卡QUALITY GATE
采检与品质确认
负责角色｜护理师、实验室
- 客户取得
- 检体收件与品质状态
- 下一步
- 合格检体进入定序流程
- 参考时程
- 预约采检日
Collection & quality
Owner | Nurse & laboratory
- Deliverable
- Specimen receipt and quality status
- Next
- Qualified specimen enters sequencing
- Timing
- Scheduled collection day
06实验与数据LAB & DATA
基因定序与分析
负责角色｜实验室、生物资讯团队
- 客户取得
- 品质控管后的变异分析资料
- 下一步
- 提交医师与专业团队判读
- 参考时程
- 依检体与检测方案确认
Sequencing & analysis
Owner | Laboratory & bioinformatics
- Deliverable
- Quality-controlled variant analysis
- Next
- Professional and physician review
- Timing
- Confirmed by specimen and test plan
07专业判读PROFESSIONAL REVIEW
医师判读报告
负责角色｜医师、专业团队
- 客户取得
- 正式报告、重点解读与限制说明
- 下一步
- 讨论可执行的健康管理方向
- 参考时程
- 分析完成后安排
Physician report review
Owner | Physician & professional team
- Deliverable
- Report, key interpretation and limitations
- Next
- Discuss actionable management direction
- Timing
- Scheduled after analysis
08个人化设计PERSONALIZATION
客制化方案或商品
负责角色｜医师、产品团队
- 客户取得
- 药物建议、保健食品建议与其他个人化方案
- 下一步
- 确认内容、使用方式与追踪指标
- 参考时程
- 完成判读后共同确认
Personalized plan or product
Owner | Physician & product team
- Deliverable
- Medication guidance, supplement guidance and other suitable support
- Next
- Confirm use and tracking indicators
- Timing
- Agreed after professional review
09正式启动ACTIVATION
交付与使用指导
负责角色｜服务专员、护理师
- 客户取得
- 方案内容、使用指导与追踪计划
- 下一步
- 开始执行并记录反应
- 参考时程
- 方案确认后启动
Delivery & guidance
Owner | Service coordinator & nurse
- Deliverable
- Plan, usage guidance and follow-up schedule
- Next
- Begin and record response
- Timing
- Starts after plan confirmation
10健康闭环HEALTH LOOP
持续追踪与复评
负责角色｜医师、护理师、服务团队
- 客户取得
- 90／180天进度、指标与调整建议
- 下一步
- 更新下一阶段方案
- 参考时程
- 90天追踪・180天复评
Follow-up & reassessment
Owner | Physician, nurse & service team
- Deliverable
- 90/180-day progress and adjustment review
- Next
- Update the next-stage plan
- Timing
- Day 90 follow-up · Day 180 review
DAY 90追踪执行情况、反应与指标变化Review execution, response and indicator changesDAY 180完整复评，更新下一阶段方案Reassess and update the next-stage plan
实际服务内容、角色配置与时程依个案、检体、方案及适用规范确认。个人化商品或方案须经专业评估，不以单一基因结果直接决定。
Service scope, roles and timing depend on the case, specimen, selected plan and applicable requirements. A personalized product or plan requires professional assessment and is not determined by a genetic result alone.
实际检测范围、检体类型、时程与报告内容，将依服务方案、检体品质、适用法规及专业评估确认。癌症基因结果需由合格医疗专业人员结合病理与临床资讯判读，不单独构成诊断或治疗决策。
Scope, specimen type, turnaround time and report content depend on the selected service, specimen quality, applicable regulations and professional review. Cancer genomic results must be interpreted by qualified healthcare professionals with pathology and clinical information and do not independently constitute a diagnosis or treatment decision.
03 · SCIENCE
实证研究
从机制、生物资讯到人体研究，基诺华持续建立可以公开检视的证据链。
Evidence-based medicine
From mechanisms and bioinformatics to human studies, Geninova builds an evidence chain that can be examined openly.
从研究设计，看懂实证。
Understand the evidence through the study design.
DOI: 10.1016/j.foodres.2025.117820 ↗
OPEN ACCESS · 2026FOOD RESEARCH INTERNATIONAL · 223 (2026) 117820
Dibifree 人体随机对照研究
40名第二型糖尿病成人参与7个月随机、双盲、安慰剂对照交叉研究；研究中的Dibifree作为既有治疗的加成性膳食介入。
研究结果应依原始论文与个人医疗情况解读，不代表疾病治疗核准或个人效果保证。
Dibifree randomized controlled human study
Forty adults with type 2 diabetes participated in a seven-month randomized, double-blind, placebo-controlled crossover study. Dibifree was evaluated as an add-on dietary intervention to existing therapy.
Results should be interpreted with the original paper and individual medical context. They do not constitute treatment approval or a guarantee of personal outcomes.
READING THE EVIDENCE
研究看到了什么？
What did the study observe?
3 MONTHS
血糖与糖化血色素
Glucose and HbA1c
论文报告三个月时，空腹血糖与 HbA1c 的组间改善；研究期间原有降糖药维持不变。
The paper reports between-group improvements in fasting glucose and HbA1c at three months, with existing glucose-lowering medicines maintained.
7 MONTHS
体重与体组成指标
Weight-related outcomes
七个月研究报告体重、BMI 与估算体脂的组间差异。研究对象为第二型糖尿病成人。
The seven-month study reports between-group differences in weight, BMI and estimated body fat in adults with type 2 diabetes.
MECHANISMS
从机制到人体，分层阅读
Read mechanisms and human results separately
论文也包含细胞与动物实验，探索 GLP-1 等相关路径；这些机制结果不等于与 GLP-1 药物并用的临床验证。
Cell and animal experiments also explore pathways including GLP-1. These mechanistic findings do not establish clinical effects of co-use with GLP-1 medicines.
这是一项 40 人的小型研究。研究结果与个人见证应分开理解；不能直接推论为所有减重族群的效果，也不能作为一个月减重公斤数的保证。
This small study enrolled 40 people. Study results and personal accounts should be read separately; the findings cannot directly establish outcomes for all weight-management populations or guarantee a one-month weight change.
Food Research International · 223 (2026) 117820 · DOI: 10.1016/j.foodres.2025.117820 ↗
植物与配方研究
植物来源、活性成分与配方逻辑。
Plants & Formulation
Sources, active compounds and formulation rationale.
机制与生物资讯
路径分析、功能实验与研究假设。
Mechanism & Bioinformatics
Pathway analysis, functional assays and research hypotheses.
人体研究
规范研究、安全观察与相关指标。
Human Research
Structured studies, safety observation and relevant outcomes.
产品与服务转化
把证据转化为可执行的健康支持。
Translation
Turn evidence into practical health support.
TWO EVIDENCE TRACKS
两条证据链，证明基诺华具备跨层级研发能力。
研究从计算与机制假设出发，接续实验验证或人体研究。不同层级回答不同问题，也各自保留应有的应用边界。
Two evidence tracks demonstrate research across multiple levels.
Work begins with computational and mechanistic hypotheses, then advances through experimental validation or human studies. Each level answers a different question and keeps an appropriate boundary for use.
计算研究与实验验证
以基因表达特征及资料库匹配提出候选方向，再以细胞与生化方法进一步验证，相关成果于国际期刊发表。
Computational and experimental validation
Gene-expression signatures and database matching generated candidate directions, followed by cellular and biochemical validation and international publication.
- 基因表达特征
- 计算匹配
- 细胞与生化验证
人体研究与多路径分析
研究涵盖随机、双盲、安慰剂对照交叉设计，并结合转录体及功能实验分析相关作用路径。
Human study and multi-pathway analysis
The program includes a randomized, double-blind, placebo-controlled crossover study together with transcriptomic and functional analyses.
- ClinicalTrials.gov 公开登记
- 40人论文分析样本
- Food Research International 同侪审查
研究证据用于说明公司的研发与转化能力。个人健康应用仍需依研究层级、法规要求及专业医疗判断进行。
Research evidence demonstrates Geninova's R&D and translation capabilities. Individual health applications remain subject to evidence level, regulation and professional clinical judgment.
05 · FOR CLINICIANS
让数据、证据与
照护流程
真正接得起来。
为医师、营养师、药师、健检与研究团队提供研究资料、专业判读与合作入口。
Connect data, evidence
and care
in practice.
A professional gateway for clinicians, dietitians, pharmacists, screening centers and research teams.
CLINICAL COLLABORATION
以专业判读为核心的合作流程
A collaboration pathway centered on professional interpretation
资料整合
依个案与服务情境，整合适用的基因、临床指标、生活方式、用药与病史资讯。
Data integration
Combine relevant genetics, clinical markers, lifestyle, medication and history for the care context.
专业判读
辨识风险、限制与管理优先序，让报告成为可讨论、可采取行动的依据。
Professional interpretation
Identify risk, limitations and priorities so reports can support informed, practical decisions.
干预与转介
依专业角色共同规划适当的营养、生活方式、植物方案、医疗追踪或必要转介。
Intervention and referral
Coordinate suitable nutrition, lifestyle, botanical support, clinical follow-up or referral.
追踪与复评
以90／180天节点回看依从性、指标与反应，作为下一阶段调整依据。
Follow-up and reassessment
Review adherence, markers and response at 90/180 days to guide the next stage.
EVIDENCE ACCESS
直接查看公开研究资料
相关人体研究已具公开试验登记及同侪审查论文。合作评估应以完整研究资料、适用情境及个案条件为准。
Review the public evidence directly
Relevant human research includes public trial registration and a peer-reviewed paper. Collaboration decisions should consider the complete study, use context and patient factors.
06 · PARTNERSHIPS
从一项研究出发，
连结全球改变的力量。
Geninova 持续探索既有药物在糖尿病并发症研究中的创新可能，汇聚全球临床、科研、产业与投资伙伴，推动科学成果从实验室走向验证、应用与国际市场，共同开创全球代谢健康的新未来。
From One Study
to Global Change.
Geninova explores new possibilities for existing medicines in diabetes-complication research, bringing together clinical, research, industry and investment partners worldwide to move science from the laboratory toward validation, application and international markets—and shape a new future for global metabolic health.
GENINOVA精准生命健康平台PRECISION HEALTH PLATFORM
DATA生命数据Life data
SCIENCE实证研究Evidence
CARE个人化管理Personalized care
IMPACT追踪成果Measured outcomes
资料进入平台后，经专业判读形成方案；90／180天结果再回到模型，持续更新下一阶段。
Data enters the platform, becomes an interpreted plan, and returns through 90/180-day outcomes to improve the next stage.
临床照护合作
Clinical care collaboration
与医疗院所、诊所及健康管理中心，共同讨论营养介入、卫教、适用的数据追踪与照护衔接。
Work with hospitals, clinics and health centers to plan nutritional support, education, relevant tracking and care coordination.
洽谈合作Discuss collaborationAI 平台合作
AI platform collaboration
以 AI Metabolic OS／AI Health Twin 为合作方向，评估资料整合、专业判读、服务流程及模组授权的需求。
Explore AI Metabolic OS / AI Health Twin collaboration, assessing data integration, professional interpretation, service workflows and module licensing.
洽谈合作Discuss collaboration市场代理合作
Market and distribution
以 Dibifree180® 产品、营养卫教与持续服务为核心，依各地市场与服务对象规划经销或代理合作。
Build distribution partnerships around Dibifree180®, nutritional education and ongoing service, adapted to the market and audience.
洽谈合作Discuss collaboration整合健康服务
Integrated health programs
与企业健康、健康管理及生活服务伙伴，讨论会员陪伴、饮食支持、长期追踪及跨团队分工。
Co-design member support, nutrition programs, follow-up and team responsibilities with workplace wellness, health-management and lifestyle partners.
洽谈合作Discuss collaborationGLOBAL CREATOR COLLABORATION
把真实经验，变成有用的内容。
Turn real experiences into useful content.
欢迎分享 GLP-1 使用历程、体重管理或营养生活的创作者，与我们一起把配方资讯、日常纪录和研究说清楚。
We welcome creators covering GLP-1 journeys, weight management and everyday nutrition to explore collaboration on clear formulation information, daily records and research.
合作从你的受众、市场与内容构想开始。内容审阅、合作揭露与成效追踪方式，在洽谈时共同确认。
Start with your audience, market and content ideas. Discuss editorial review, sponsorship disclosure and campaign measurement together.
提出创作者合作Propose a creator collaboration生活怎么记
Document everyday life
餐食、活动与个人感受，呈现真实经验与同期照护背景。
Share meals, activity and personal experiences together with the context of ongoing care.
配方怎么看
Understand the formulation
对照产品资料与原始研究，分清原料、整体配方及人体研究。
Compare product information with original research, distinguishing ingredients, the complete formula and human studies.
问题怎么问
Prepare better questions
把营养与用药疑问带进专业讨论，让观众知道下一步。
Bring questions about nutrition and medicines to qualified professionals and help viewers identify a next step.
OUR INTERNATIONAL COLLABORATION ROADMAP
从亚洲出发，连结全球伙伴。
Starting in Asia. Connecting with global partners.
我们正规划分阶段建立在地合作，邀请熟悉当地受众、语言与服务需求的伙伴一起讨论。
We are planning a phased approach to local partnerships and welcome conversations with partners who understand local audiences, languages and service needs.
- 01
亚洲优先市场
Initial Asian markets
台湾、中国、新加坡、香港、马来西亚、印尼、菲律宾
Taiwan, China, Singapore, Hong Kong, Malaysia, Indonesia and the Philippines
- 02
中东市场
Middle East
阿联酋（UAE）、沙乌地阿拉伯、卡达、阿曼
United Arab Emirates, Saudi Arabia, Qatar and Oman
- 03
欧洲与北美
Europe & North America
拓展欧洲，包括英国、爱尔兰，并同步进入北美市场
Expand into Europe, including the United Kingdom and Ireland, alongside North America
以上为市场拓展规划。产品供应、合作形式与服务内容，依各地条件及确认结果安排。
This is a market development plan. Product availability, partnership formats and services will depend on local requirements and confirmed arrangements.
洽谈在地合作Discuss a local partnershipJOIN THE JOURNEY
一起把正确的卫教，带给需要的人。
Help bring grounded education to people who need it.
网红与内容创作者
Creators & influencers
希望用内容分享 442 与营养干预？提出你的受众、平台与合作构想，一起讨论合适的呈现方式。
Share your audience, platform and ideas for communicating 442 and nutritional intervention.
提出合作意向Share your interest经销商与代理商
Distributors & agents
告诉我们所在市场与服务对象，讨论产品、卫教素材及服务衔接的合作需求。
Tell us your market and audience to discuss product, education and service-coordination needs.
提出合作意向Share your interest志愿者与社群支持
Volunteers & community support
希望参与糖友陪伴或卫教推广？留下可投入的时间与希望参与的方式。
Tell us how you would like to contribute to community support or education, and your availability.
提出合作意向Share your interestSERVICE & BUSINESS MODEL
合作关系可以从单次服务，延伸为持续健康管理。
平台收入来自检测协作与专业服务、180天个人化方案、年度会员服务，以及机构合作、联合研发与授权。
Partnerships can grow from an initial service into ongoing health management.
The model combines testing collaboration and professional services, 180-day personalized programs, annual membership, institutional programs, joint R&D and licensing.
精准健康风险地图
整合适用资料，建立管理优先序与专业沟通基础。
Precision health risk map
Integrate relevant data into priorities and a foundation for professional discussion.
180天个人化方案
把风险转成饮食、生活方式、植物营养及追踪行动。
180-day personalized program
Turn risk into nutrition, lifestyle, botanical support and follow-up actions.
年度健康长寿服务
透过定期复评与长期资料持续调整下一阶段。
Annual longevity service
Use reassessment and longitudinal data to refine each new stage.
医疗院所、健检中心、研究团队、制造与市场伙伴，都可以提出合作情境。
告诉我们服务对象、所在市场与希望解决的问题，团队将依需求评估适合的起点。
Healthcare, screening, research, manufacturing and market partners can propose a collaboration scenario.
Tell us who you serve, your market and the problem you want to solve. The team will assess a suitable starting point.
07 · CONTACT
说说你的目标，
一起找到
适合的下一步。
Dibifree180® 减糖与减重方案、产品购买、卫教咨询，以及内容推广、经销代理或志愿者参与，都可以从这里开始。
Tell us your goal.
Find your
next step.
Contact us for Dibifree180® glucose or weight support, product purchases, education, creator and distribution partnerships, or volunteering.
YOUR NEXT STEP
请留下需求与合作情境
描述越具体，我们越能安排适合的团队成员与你联系。若涉及个人健康问题，请勿在表单填写完整病历或敏感医疗资料。
Tell us about your needs
Specific context helps us connect you with the right team member. For personal health inquiries, do not submit full medical records or sensitive health data in this form.
Dibifree180® / GLUCOSE
抗糖新观念
Rethinking glucose care
抗糖，不是少吃而已。
从十项植物萃取的研究、442 饮食到 180 天陪伴，让营养介入走进每一餐、每一次选择与每天的血糖照护。
Glucose care is more than simply eating less.
From research on ten botanical extracts to 442 food guidance and 180 days of support, nutritional intervention belongs in every meal, every choice and everyday glucose care.
BOTANICALS · MECHANISMS · EVIDENCE
植萃有依据
The science behind botanicals
抗糖，从看懂原料开始。
Understand the ingredients. Explore glucose care.
一餐之后，淀粉需要经过消化分解，才能以葡萄糖的形式被吸收。从消化这一步，到身体的血糖调节，植物原料研究探索著不同的作用方向。
After a meal, starch must be digested before it can be absorbed as glucose. Botanical research explores different steps, from digestion to the body’s regulation of blood glucose.
- 淀粉分解Starch digestion
- 糖类消化Carbohydrate breakdown
- 血糖调节Glucose regulation
以下先认识 Dibifree 已发表论文研究配方中的白肾豆与苦瓜。原料试验各有萃取规格、用量及研究对象；整体配方的效果，另由 Dibifree 本身的研究评估。
Start with white kidney bean and bitter melon, listed in the published Dibifree study formulation. Ingredient trials use their own extracts, doses and populations; the complete formula is evaluated through Dibifree’s own research.
白芸豆
White kidney bean
研究淀粉分解
Studying starch digestion
白芸豆，又称白肾豆。具 α-淀粉酶抑制活性的标准化萃取物，可影响淀粉分解。原料研究以此探索体重管理的可能性，作用与萃取物活性及用量有关。
White kidney bean extracts standardized for alpha-amylase inhibition can affect starch digestion. Ingredient studies explore this approach for weight management; activity and dose matter.
一项 12 周随机试验使用特定品牌萃取物并配合热量限制饮食；研究结果应按该配方与条件解读。
A 12-week randomized trial tested a specific branded extract alongside a calorie-restricted diet. Its findings apply to that formulation and those conditions.
苦瓜
Bitter melon
探索血糖调节
Exploring glucose regulation
苦瓜萃取物的研究关注血糖与升糖素等调节讯号。一项 12 周糖尿病前期成人试验，观察到萃取物组部分葡萄糖耐受测试指标下降。
Bitter melon extract studies examine blood glucose and regulatory signals such as glucagon. A 12-week trial in adults with prediabetes observed decreases in selected glucose-tolerance-test measures within the extract group.
这是特定苦瓜萃取物的研究；不同萃取物与苦瓜胜肽，需要各自对应的资料。
This trial studied a particular bitter melon extract. Other extracts and bitter melon peptides need their own supporting data.
回到每天的实践：442 饮食、个别指导与 180 天追踪，让原料知识接上生活。442 依公司方针不纳入淀粉；含淀粉试餐的原料研究，须按原试验条件理解。
Connect ingredient knowledge with daily practice through 442 guidance, individual support and 180 days of follow-up. The company’s 442 approach excludes starchy foods; ingredient findings from starch-containing test meals must be interpreted in their original context.
了解实证研究Explore the evidenceGLP-1 · NUTRITION · DAILY CARE
照护要跟上
Care that keeps pace
食欲变了，营养需求仍要被照顾。
Appetite changes. Nutritional needs still deserve attention.
为何不舒服
Why discomfort occurs
Semaglutide（如 Wegovy）会调节食欲并延缓胃排空。恶心、呕吐、腹泻或便秘是已知的肠胃副作用，常在开始治疗或增加剂量时出现；口服与针剂都可能发生。
Semaglutide, including Wegovy, regulates appetite and delays gastric emptying. Nausea, vomiting, diarrhoea and constipation are known gastrointestinal effects, often appearing when treatment begins or doses increase. Both tablets and injections can cause them.
STEP 试验的合并分析中，多数肠胃不适为轻至中度、暂时性；有些人仍可能出现较严重反应。
In a pooled STEP analysis, most gastrointestinal events were mild to moderate and transient, although some people can experience more serious reactions.
营养怎么接
How nutrition fits
四个专业学会共同建议：GLP-1 治疗期间应评估实际进食、营养是否足够及肠胃耐受，并结合个别饮食、活动与持续支持。
Four professional societies recommend assessing food intake, nutritional adequacy and gastrointestinal tolerance during GLP-1 therapy, alongside individualized diet, activity and ongoing support.
Dibifree180® 的服务讨论从餐食、用药与生活纪录开始，再与医疗团队确认适合的营养安排。
A Dibifree180® consultation starts with meals, medicines and daily-life records, followed by discussion of an appropriate nutritional plan with the medical team.
先看耐受
Tolerance comes first
442 是公司的饮食方针。若使用 GLP-1 时有恶心、腹胀或进食困难，餐量、纤维与油脂安排需由医师或营养师依耐受性调整。专业建议提到，治疗初期可评估较小餐量、较频繁进食，并避免高脂或高纤餐加重不适；不能直接套用固定比例来处理副作用。
442 is the company’s dietary approach. If GLP-1 treatment causes nausea, bloating or difficulty eating, a clinician or dietitian should adapt meal size, fibre and fat to tolerance. The advisory discusses smaller, more frequent meals and avoiding fatty or high-fibre foods early in treatment. A fixed ratio is not a treatment for side effects.
口服药与补充品的服用间隔，请依所用药品仿单向药师确认。持续呕吐、喝不下水或严重腹痛，请及时就医。
Confirm oral medicine and supplement timing with a pharmacist using your medicine’s instructions. Seek prompt medical care for persistent vomiting, inability to keep fluids down or severe abdominal pain.
442 / FOOD EDUCATION
先学会选择，再一起调整。
Learn the choices. Adjust together.
442 饮食方针不纳入淀粉类食物。
The 442 approach excludes starchy foods.
膳食纤维
Dietary fibre
地瓜叶・苦瓜・秋葵・高丽菜
Sweet potato leaves · bitter melon · okra · cabbage
优质蛋白质
Quality protein
鱼・肉・豆・蛋
Fish · meat · soy foods · eggs
好油
Good oils
橄榄油・酪梨油・苦茶油
Olive · avocado · camellia oils
依公司 442 饮食方针整理；个别食材选择与实际份量，由卫教团队协助确认。
Based on company education records and the confirmed approach. Percentages are not converted into calories, weight or plate area; discuss portions with the team.
DAILY SUPPORT
每一天，你与卫教团队如何合作？
How do you work with the team each day?
记录
Record
依团队确认的方式记录晨起与餐后血糖，餐前拍下三餐内容。
Record morning and post-meal glucose as agreed with your team, and photograph meals before eating.
回馈
Review
把照片与数据一起交给团队，讨论蔬菜、蛋白质、好油与执行困难。
Share photos and values to discuss vegetables, protein, oils and practical difficulties.
持续
Continue
按周追踪体重，按团队安排回顾检验；药物调整由处方医师评估。
Track weight weekly and review tests as arranged. Medication changes are assessed by your prescribing clinician.
180 DAYS / YOUR DAILY PRACTICE
有人陪你，把原则变成生活。
Support that turns principles into practice.
了解你的起点
Know your starting point
整理现有检验、用药与生活情况，讨论减糖或减重的个人目标。
Review existing tests, medications and daily life, then discuss personal glucose or weight goals.
把 442 放进每一天
Bring 442 into daily life
用三餐照片、血糖纪录与体重追踪，把饮食方针变成能持续的习惯。
Use meal photos, glucose records and weight tracking to build a repeatable routine.
30 天回看，持续调整
Review the first 30 days
回看资料是否完整、餐食是否适合、遇到哪些困难；记录实际变化。
Review record completeness, meals and practical difficulties; document actual changes.
走到 180 天，也看下一步
Reach day 180 and plan ahead
依团队安排定期回顾，于阶段结束整理进度，讨论接下来如何维持。
Review periodically with the team, assess progress at the end and discuss maintenance.
具体频率与服务内容于咨询确认。研究期程另见科研证据。
Confirm service scope and frequency during consultation. The clinical study has a separate timeline.
FROM OUR COMPANY MENUS
把原始菜单，带进今天的备餐。
Bring the original menu ideas into today’s preparation.
花椰菜米搭配
Cauliflower-rice pairing
公司原始菜单：花椰菜米搭配虾仁、鲑鱼或碎牛肉，再安排蔬菜与好油。这里的「米」是花椰菜，不是白米。
Original menu: cauliflower rice with shrimp, salmon or minced beef, alongside vegetables and good oils. “Rice” here refers to cauliflower, not grain.
蒟蒻面搭配
Konjac-noodle pairing
公司原始菜单：蒟蒻面搭配牛肉块、猪肉片或综合海鲜。依不纳入淀粉的方针，选购时与团队确认配料，避免混入一般面粉或淀粉的产品。
Original menu: konjac noodles with beef, pork or seafood. Within the no-starchy-food approach, check ingredients with the team rather than using products mixed with ordinary flour or starch.
蔬菜与搭配
Vegetables and accompaniments
原始清单列有地瓜叶、芹菜、龙须菜、彩椒、大番茄、洋葱、苦瓜，以及油醋酱；与蛋白质、好油一起规划。
The original list includes sweet potato leaves, celery, chayote shoots, peppers, tomatoes, onions, bitter melon, and oil-vinegar dressing. Plan these with protein and good oils.
来源：公司《卫教 QA》原始工作簿，索引 20、39；食材与实际份量请依个人方案确认。
Source: company education Q&A workbook, indices 20 and 39. Confirm ingredients and portions within your individual plan.
第七版个人卫教纪录；不作为 GLP-1 并用效果的证据。
A seventh-edition personal education account; this is not evidence of effects from co-use with GLP-1 treatment.
A RECORDED JOURNEY
第七版 No.7｜把运动从「知道」变成「做到」
Seventh edition No.7 | Turning knowledge into a routine
这位糖友原本不重视运动，也担心糖尿病对日常生活的影响。参与卫教课程后，纪录描述她开始使用跑步机，透过云端回报接受持续辅导。
This participant had not made exercise a priority and was concerned about diabetes in daily life. The account describes starting treadmill activity after education sessions and receiving ongoing support through online reporting.
HbA1c：6.7% → 5.9%
2020/11/18 → 2021/06/30；七版第 25 页计划成果表。此处为第 7 个月的纪录。
2020/11/18 → 2021/06/30; results table, p.25. The value shown is the month 7 record.
见证包含饮食、运动与其他照护的共同变化；不能由单一个案判定产品效果。
The account includes simultaneous changes in diet, activity and other care; one case cannot establish product efficacy.
REAL PEOPLE · 60 SECONDS
一分钟见证
One-minute stories
你的经历，值得被听见。
Your experience deserves to be heard.
邀请分享 60 秒真实经历：用药背景、开始前后的感受与追踪时间。影片会一并交代同期的用药、饮食或活动变化。
Share a 60-second account covering treatment background, before-and-after experiences and follow-up time, alongside any changes in medicines, meals or activity.
个人经验不能单独证明产品降低副作用或预防复胖；影片内容须由本人确认并同意公开。
A personal account alone cannot establish that a product reduces side effects or prevents regain. Each contributor must confirm the content and agree to publication.
分享经历Share your experience让日常纪录，与研究依据一起阅读。
Read everyday records alongside the research.
Dibifree 的人体研究纳入 40 位第二型糖尿病成人，研究期间为 7 个月。了解参与者、研究设计与结果，有助于判断它对自己的意义。
The seven-month Dibifree study enrolled 40 adults with type 2 diabetes. Examine its participants, design and results to understand its relevance.
查看人体研究与期刊Explore the human study and paperGENINOVA · DIABETES & WEIGHT GENOMICS
糖尿与减重，
从理解差异开始。
Diabetes and weight.
Start with understanding.
整合家族史、代谢指标与生活纪录，由专业评估决定基因检测的角色，再连结个人化管理。
Combine family history, metabolic measurements and daily records to assess where genetic testing can inform personalized care.
适合先咨询的情境
When to discuss testing
- 糖尿病家族史、年轻发病或分型疑问Family history, early-onset diabetes or uncertainty about diabetes type
- 体重管理需求，或疑似早发、遗传性肥胖Weight-management needs or suspected early-onset genetic obesity
- 希望整合现有报告、生活习惯与医疗建议A need to connect existing reports, habits and clinical advice
YOUR SERVICE JOURNEY
从咨询到追踪，服务如何进行？
How does the service work?
由基诺华服务窗口协调，让每一步都有清楚的衔接。
A Geninova service contact coordinates each stage.
- 01
咨询与需求确认
Consultation
服务专员整理糖尿、体重与家族史问题。
A coordinator clarifies diabetes, weight and family-history concerns.
- 02
医师评估
Clinical assessment
结合病史、血糖及代谢资料，决定是否检测。
A clinician reviews history and metabolic data to assess testing value.
- 03
方案与采检
Plan and collection
说明范围、限制、费用与时程，完成同意后安排适用检体。
Confirm scope, limitations, cost and timing before consent and suitable collection.
- 04
定序与专业判读
Analysis and interpretation
依核定方案进行品质控管与分析，解释结果及不确定性。
Perform agreed quality checks and analysis; explain results and uncertainty.
- 05
个人化方案
Personalized plan
医师／营养师整合结果，讨论药物、营养、活动与合适的保健食品。
Clinicians integrate findings into medication, nutrition, activity and appropriate supplement guidance.
- 06
90／180天追踪
90/180-day follow-up
追踪执行情况与代谢变化，依医疗判断调整。
Review implementation and metabolic trends; adjust with clinical guidance.
你会得到什么？
What will you receive?
- 检测范围与检前说明Testing scope and pre-test explanation
- 报告解读与限制说明Report interpretation and limitations
- 个人化管理及追踪方向Personalized management and follow-up direction
多久完成？费用如何计算？How long does it take, and what does it cost?
依检测范围、检体品质与医师安排，在确认方案时提供预估时程与费用。
Estimated timing and cost are provided when the scope, specimen and clinical arrangements are confirmed.
第一次咨询需要准备什么？What should I prepare for the first consultation?
先提供联络方式与想了解的项目即可。病历、基因报告等敏感资料，请待专人说明安全交付方式。
Start with contact details and the service of interest. Wait for secure-transfer instructions before sharing records or genomic reports.
让专人协助你确认下一步。
Let us help clarify your next step.
从需求开始，讨论适合的评估与服务安排。
Start with your needs and discuss suitable assessment and service arrangements.
GENINOVA · IMMUNE DYSREGULATION GENOMICS
理解免疫失衡，
找到评估的下一步。
Understand immune imbalance.
Clarify the next step.
从反复感染、发炎表现与家族史出发，协助专科医师评估遗传因素是否值得进一步检查。
Start with infection patterns, inflammatory features and family history to support specialist assessment of possible genetic factors.
先厘清临床问题，再决定检测
Define the clinical question first
- 反复或异常感染，已由医师建议进一步评估Recurrent or unusual infections warranting specialist review
- 免疫失调或自体免疫表现合并遗传性疾病疑虑Immune dysregulation with concern for an inherited condition
- 既有检查尚未厘清，需整合家族与临床资讯Unresolved findings requiring family and clinical context
YOUR SERVICE JOURNEY
从咨询到追踪，服务如何进行？
How does the service work?
由基诺华服务窗口协调，让每一步都有清楚的衔接。
A Geninova service contact coordinates each stage.
- 01
服务咨询
Consultation
先厘清就医背景与检测目的。
Clarify the clinical background and purpose of testing.
- 02
免疫专科评估
Specialist assessment
由专科医师整合症状、感染史与既有免疫检验。
A specialist reviews symptoms, infections and existing immune tests.
- 03
检前说明与采检
Consent and collection
依临床问题确认检测范围与合适检体。
Confirm an appropriate testing scope and specimen.
- 04
基因分析与判读
Genetic analysis
将变异与临床表现对照，说明致病性与证据限制。
Interpret variants against the clinical picture and strength of evidence.
- 05
报告咨询与转介
Review and referral
讨论结果、不确定变异，以及是否需要遗传咨询或进一步检查。
Discuss uncertain variants, genetic counseling and further evaluation where needed.
- 06
个人化追踪
Individual follow-up
由医师安排疾病追踪；护理与服务团队协助纪录与联系。
The physician sets clinical follow-up; the service team supports records and coordination.
你会得到什么？
What will you receive?
- 检前资讯与检体安排Pre-test information and collection planning
- 专业报告与结果咨询Professional report and results consultation
- 专科衔接与追踪建议Specialist coordination and follow-up advice
多久完成？费用如何计算？How long does it take, and what does it cost?
依检测范围、检体品质与医师安排，在确认方案时提供预估时程与费用。
Estimated timing and cost are provided when the scope, specimen and clinical arrangements are confirmed.
第一次咨询需要准备什么？What should I prepare for the first consultation?
先提供联络方式与想了解的项目即可。病历、基因报告等敏感资料，请待专人说明安全交付方式。
Start with contact details and the service of interest. Wait for secure-transfer instructions before sharing records or genomic reports.
让专人协助你确认下一步。
Let us help clarify your next step.
从需求开始，讨论适合的评估与服务安排。
Start with your needs and discuss suitable assessment and service arrangements.
INDIVIDUAL CONTACT
个别咨询
Individual inquiries
Dibifree180® / WEIGHT
减重智取胜
Smarter weight management
减下来的每一天，也为长期维持做准备。
从 GLP-1 治疗到生活安排，让营养、纪录与陪伴一起接上。
Plan for long-term maintenance as you lose weight.
Connect GLP-1 care with nutrition, records and ongoing support.
WEIGHT LOSS · LONG-TERM CARE
减后怎么走
What comes after weight loss
把长期维持，放进今天的计划。
Make long-term maintenance part of today’s plan.
为何会回升
Why weight can return
停止治疗后，药物对食欲与饱足感的作用会消退；减重后的生理调节也可能增加饥饿感。体重管理因此需要长期安排，复胖不能只归咎于意志力。
After treatment stops, the medicine’s effects on appetite and satiety fade. Biological adaptations after weight loss can also increase hunger, making long-term planning important; weight regain is not simply a matter of willpower.
Tirzepatide 是 GIP／GLP-1 双重受体促效剂；其停药研究也观察到体重回升。不同药物、剂量与族群的结果应分开解读。
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Its withdrawal trial also observed weight regain. Results should be interpreted separately for each medicine, dose and population.
STEP 1 EXTENSION
约 2/3~2/3先前减掉的体重，在停用后一年平均回升。
Of prior weight loss was regained, on average, one year after withdrawal.
此延伸分析纳入 327 位无糖尿病的过重或肥胖成人；第 68 周同时停止 semaglutide 2.4 mg 针剂与试验生活介入。这是特定研究的平均结果，不是每个人的必然结局。
The extension included 327 adults with overweight or obesity without diabetes. Semaglutide 2.4 mg injections and the trial’s lifestyle intervention both stopped at week 68. This study average does not predict every person’s outcome.
剂量看医嘱
Dose decisions are clinical
Wegovy 等药物的剂量与调整速度，依治疗反应、耐受性及医嘱决定。把用药与生活纪录带回诊间，由处方医师评估调整的时机与方式，让营养照护与医疗安排相互衔接。
Dose and titration decisions for medicines such as Wegovy depend on response, tolerability and prescribing guidance. Bring medication and daily-life records to appointments so your prescriber can assess when and how to adjust treatment, alongside nutritional care.
把生活接上
Connect care with daily life
把进食状况、蛋白质与水分、活动和体重趋势带进追踪；在治疗调整前，先与团队谈好后续安排。Dibifree180® 的营养支持可作为个别咨询内容，让营养安排与长期追踪一起成为照护计划的一部分。
Track intake, protein and hydration, activity and weight trends. Discuss follow-up before treatment changes. Explore Dibifree180® nutritional support in an individual consultation, connecting nutrition planning with long-term follow-up.
FIRST 30 DAYS
第一个月，看见自己的起点与进度。
Use the first month to establish your baseline and progress.
先留下起点
Record the baseline
整理体重、平日餐食、活动与正在使用的产品或药物，先让团队了解你。
Share weight, usual meals, activity and current products or medicines so the team can understand your situation.
让纪录持续
Keep a weekly record
依原始卫教建议至少每周记录体重，配合餐照回馈，检查 442 是否落实。
The source guidance suggests at least weekly weight records, alongside meal-photo feedback and review of the 442 approach.
用实际资料回顾
Review actual progress
比较起点与目前纪录，讨论饮食和生活上的困难；以实际纪录了解个人的进度。
Compare current records with your baseline and discuss dietary and lifestyle difficulties without a guaranteed kilogram target.
442 / NUTRITION
减重的日常，也从营养组成开始。
Build your weight-management routine around nutrition.
442 饮食方针不纳入淀粉类食物。
The 442 approach excludes starchy foods.
膳食纤维
Dietary fibre
地瓜叶・苦瓜・秋葵・高丽菜
Sweet potato leaves · bitter melon · okra · cabbage
优质蛋白质
Quality protein
鱼・肉・豆・蛋
Fish · meat · soy foods · eggs
好油
Good oils
橄榄油・酪梨油・苦茶油
Olive · avocado · camellia oils
依公司 442 饮食方针整理；个别食材选择与实际份量，由卫教团队协助确认。
Based on company education records and the confirmed approach. Percentages are not converted into calories, weight or plate area; discuss portions with the team.
180 DAYS / YOUR DAILY PRACTICE
有人陪你，把原则变成生活。
Support that turns principles into practice.
了解你的起点
Know your starting point
整理现有检验、用药与生活情况，讨论减糖或减重的个人目标。
Review existing tests, medications and daily life, then discuss personal glucose or weight goals.
把 442 放进每一天
Bring 442 into daily life
用三餐照片、血糖纪录与体重追踪，把饮食方针变成能持续的习惯。
Use meal photos, glucose records and weight tracking to build a repeatable routine.
30 天回看，持续调整
Review the first 30 days
回看资料是否完整、餐食是否适合、遇到哪些困难；记录实际变化。
Review record completeness, meals and practical difficulties; document actual changes.
走到 180 天，也看下一步
Reach day 180 and plan ahead
依团队安排定期回顾，于阶段结束整理进度，讨论接下来如何维持。
Review periodically with the team, assess progress at the end and discuss maintenance.
具体频率与服务内容于咨询确认。研究期程另见科研证据。
Confirm service scope and frequency during consultation. The clinical study has a separate timeline.
FROM OUR COMPANY MENUS
把原始菜单，带进今天的备餐。
Bring the original menu ideas into today’s preparation.
花椰菜米搭配
Cauliflower-rice pairing
公司原始菜单：花椰菜米搭配虾仁、鲑鱼或碎牛肉，再安排蔬菜与好油。这里的「米」是花椰菜，不是白米。
Original menu: cauliflower rice with shrimp, salmon or minced beef, alongside vegetables and good oils. “Rice” here refers to cauliflower, not grain.
蒟蒻面搭配
Konjac-noodle pairing
公司原始菜单：蒟蒻面搭配牛肉块、猪肉片或综合海鲜。依不纳入淀粉的方针，选购时与团队确认配料，避免混入一般面粉或淀粉的产品。
Original menu: konjac noodles with beef, pork or seafood. Within the no-starchy-food approach, check ingredients with the team rather than using products mixed with ordinary flour or starch.
蔬菜与搭配
Vegetables and accompaniments
原始清单列有地瓜叶、芹菜、龙须菜、彩椒、大番茄、洋葱、苦瓜，以及油醋酱；与蛋白质、好油一起规划。
The original list includes sweet potato leaves, celery, chayote shoots, peppers, tomatoes, onions, bitter melon, and oil-vinegar dressing. Plan these with protein and good oils.
来源：公司《卫教 QA》原始工作簿，索引 20、39；食材与实际份量请依个人方案确认。
Source: company education Q&A workbook, indices 20 and 39. Confirm ingredients and portions within your individual plan.
第七版个人卫教纪录；不作为 GLP-1 并用效果的证据。
A seventh-edition personal education account; this is not evidence of effects from co-use with GLP-1 treatment.
A RECORDED JOURNEY
第七版 No.6｜聚餐压力，也需要有人一起面对
Seventh edition No.6 | Support through social-meal pressure
这位糖友曾习惯以含糖饮料代替水。见证描述他调整餐食，选择蛋白质、纤维蔬菜与好油，同时由家人协助备餐、同伴互相鼓励；也坦言朋友劝吃会影响执行。
This participant described a habit of sweet drinks, then changes toward protein, fibrous vegetables and good oils. Family meal preparation and peer encouragement helped, while social pressure remained a challenge.
体重自述：88 kg → 78 kgSelf-reported weight: 88 kg → 78 kg
自述为开始后两个月的变化；七版第 23–24 页。此为第二型糖尿病个案的经验，个人结果不代表所有人的减重幅度。
Self-reported change over the first two months; pp.23–24. This is an account from a participant with type 2 diabetes, not an independent weight-loss trial or a one-month promise.
见证包含饮食、运动与其他照护的共同变化；不能由单一个案判定产品效果。
The account includes simultaneous changes in diet, activity and other care; one case cannot establish product efficacy.
REAL PEOPLE · 60 SECONDS
一分钟见证
One-minute stories
你的经历，值得被听见。
Your experience deserves to be heard.
邀请分享 60 秒真实经历：用药背景、开始前后的感受与追踪时间。影片会一并交代同期的用药、饮食或活动变化。
Share a 60-second account covering treatment background, before-and-after experiences and follow-up time, alongside any changes in medicines, meals or activity.
个人经验不能单独证明产品降低副作用或预防复胖；影片内容须由本人确认并同意公开。
A personal account alone cannot establish that a product reduces side effects or prevents regain. Each contributor must confirm the content and agree to publication.
分享经历Share your experience让日常纪录，与研究依据一起阅读。
Read everyday records alongside the research.
Dibifree 的人体研究纳入 40 位第二型糖尿病成人，研究期间为 7 个月。了解参与者、研究设计与结果，有助于判断它对自己的意义。
The seven-month Dibifree study enrolled 40 adults with type 2 diabetes. Examine its participants, design and results to understand its relevance.
查看人体研究与期刊Explore the human study and paper